Atopic Dermatitis

Multiple measurements of skin integrity and function were applied to distinguish between the effects of topical emollient products in a recent study. Two popular products in the UK were determined to transiently improve the skin barrier that is thought to be defective in atopic dermatitis (AD), and another product was confirmed to be damaging.

Researchers report that atopic dermatitis (AD) is associated with increased risk of ADHD in adults and children. Patients with more severe AD were at even higher risk.

A modified Goeckerman regimen was associated with significant improvement of symptoms in patients with chronic, severe atopic dermatitis.

Severe atopic dermatitis (AD) symptoms of shorter duration were more likely to improve in allergen sensitized patients receiving desensitizing immunotherapy, than severe symptoms of longer duration or more moderate symptoms, according to a new observational cohort study.

Childhood atopic dermatitis (AD) usually resolves before adulthood, a meta-analysis of cases showed. Those patients who did see their AD persist were more likely to be female, to have been older at onset, and to have relatively severe AD.

Across the board, researchers saw that studies of active smokers showed increased prevalence of the skin condition, regardless of age or region. It isn't quite clear, though, whether smoking causes AD or AD causes people to smoke.

Topical corticosteroid worked as well as bleach in transforming the microbiota of affected skin to that of healthy skin, an NYU study found.

In the past 15 years, no new topical AD treatments have been approved. Crisaborole, however, could be an efficient, safe, non-steoidal treatment option, according to the results of two recent phase III studies.

For millions of Americans, including as many as one in four children, the painful skin irritation of atopic dermatitis (AD, or eczema), may only be the tip of the iceberg.

Researchers have reported that higher serum clusterin levels in children may be linked with atopic dermatitis symptom, potentially providing a candidate molecule to reflect disease’s severity.

Researchers have reported that higher serum clusterin levels in children may be linked with atopic dermatitis symptom severity.

From childhood to adulthood atopic dermatitis is a condition that can have an extremely negative impact on a person's life. Knowing the best way to manage the symptoms can go a long way in improving quality of life issues.

Staph is often present in patients with atopic dermatitis, study finds.

Although preclinical trials have shown that mesenchymal stem cells (MSCs) are therapeutically effective against atopic dermatitis, actual clinical studies had not yet confirmed it – until now.

Dermatologists have long advised against giving daily baths to kids suffering from eczema, but new research has debunked that practice – a daily wash is acceptable, followed by plenty of moisturizer.

Atopic dermatitis, sometimes referred to as baby eczema, affects more than three million infants in the United States every year. While there are no established preventive measures, researchers have been making strides in coming up with effective treatment strategies.

The American Academy of Dermatology (AAD) recently released new recommendations encouraging physicians to thoroughly inform patients of their options when it comes to dermatologic medications and procedures.

Atopic dermatitis is the most common inflammatory pediatric skin disorder, with reported incidences ranging from 10% to 20%. The principles of effect care include fixing the skin barrier, short-circuiting inflammation, decreasing itching, treating infections, and striving for prevention by addressing the triggers.

A defect in a deeper layer of the skin known as the "tight junctions" may play a key role in the development of atopic dermatitis.

Study shows demographic and geographic variability in prevalence, with higher rates among African Americans, city dwellers, and on the East Coast.